Neurocrine Biosciences Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | 1,199.4 | 323.8 | – | 442.9 | 410.6 | 282.3 | 47.6 | 58.5 | 96.1 | 22.9 | 23.8 | 26.1 | 21.1 | 90.2 | 128.2 | 764.0 | 180.6 | 77.9 | 153.5 | 53.6 | 59.5 | 54.0 | 38.6 | 42.2 | 31.1 | 41.2 | 37.1 | 36.5 | 33.6 | 30.4 | 20.4 | 24.9 | |
| 55.0 | 44.8 | 63.0 | 111.5 | 65.9 | 44.5 | 31.9 | 27.4 | 28.7 | 15.1 | 15.5 | 13.2 | 12.8 | 13.3 | 9.5 | 11.9 | 8.6 | 8.9 | 9.1 | 9.2 | 8.8 | 7.1 | 7.6 | 7.2 | 7.6 | 8.1 | 6.1 | 5.6 | 6.4 | 7.1 | 7.2 | 6.8 | 5.4 | 6.0 | 4.7 | 5.1 | 5.4 | 5.1 | 4.4 | 5.2 | |
| 12.5 | 10.7 | 15.3 | 11.7 | 15.6 | 19.3 | 20.4 | 23.4 | 26.6 | 14.2 | 19.6 | 16.5 | 15.1 | 16.4 | 12.0 | 14.4 | 11.2 | 8.3 | 7.9 | 7.4 | 7.0 | 5.9 | 6.6 | 6.5 | 6.8 | 7.0 | 5.8 | 5.1 | 5.7 | 6.0 | 6.0 | 5.7 | 4.4 | 5.4 | 4.5 | 4.7 | 4.8 | 4.5 | 4.0 | 4.8 | |
| 54.0 | 43.9 | 62.1 | 122.8 | 71.6 | 45.4 | 34.4 | 29.2 | 29.2 | 15.8 | 16.1 | 13.6 | 13.2 | 14.2 | 9.7 | 11.9 | 8.6 | 9.1 | 9.8 | 9.3 | 9.0 | 7.3 | 7.7 | 7.2 | 7.6 | 8.0 | 6.2 | 5.7 | 6.3 | 7.1 | 7.1 | 6.7 | 5.2 | – | – | – | 5.3 | – | – | – | |
| – | – | – | – | – | – | – | – | 277.6 | 126.7 | – | 147.3 | 137.0 | 129.8 | 37.8 | 46.1 | 61.8 | 64.5 | 76.3 | 89.0 | 49.9 | 60.1 | 71.8 | 204.0 | 96.2 | 50.5 | 88.4 | 37.0 | 41.0 | 37.6 | 25.0 | 23.9 | 17.6 | – | – | – | 20.8 | – | – | – | |
| – | – | – | – | – | – | – | 5,414.8 | 169.3 | 89.3 | 18,324.0 | 180.6 | 105.5 | 76.1 | 29.2 | 35.0 | 39.5 | 44.0 | 36.7 | 38.8 | 29.1 | 34.7 | 89.6 | 70.3 | 59.4 | 37.3 | 41.4 | 33.6 | 29.6 | 37.3 | 23.3 | 28.9 | 27.3 | 25.2 | 23.0 | 24.0 | 24.3 | 19.4 | 16.4 | 20.2 | |
| -2.1% | -3.3% | -4.2% | -4.7% | -3.2% | -1.4% | -0.8% | 0.0% | 0.6% | 1.1% | 0.0% | 0.6% | 0.9% | 1.3% | 3.4% | 2.9% | 2.5% | 2.3% | 2.7% | 2.6% | 3.4% | 2.9% | 1.1% | 1.4% | 1.7% | 2.7% | 2.4% | 3.0% | 3.4% | 2.7% | 4.3% | 3.5% | 3.7% | 4.0% | 4.3% | 4.2% | 4.1% | 5.2% | 6.1% | 5.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 1.2% | -7.9% | -34.8% | -40.3% | 55.7% | 99.2% | 99.1% | 99.1% | 99.0% | 98.9% | 99.0% | 99.0% | 99.0% | 99.1% | 99.1% | 99.1% | 99.1% | 99.0% | 99.0% | 98.9% | 98.8% | 98.7% | 98.7% | 98.6% | 98.6% | 98.4% | 98.3% | 98.0% | 97.8% | 97.9% | 98.0% | 98.3% | 98.5% | 98.6% | 98.5% | 98.5% | 98.4% | 98.2% | 98.2% | 98.0% | |
| -165.3% | -196.5% | -344.1% | -610.7% | -230.7% | -81.3% | -38.2% | -10.4% | 6.5% | 8.2% | -5.1% | 1.6% | 6.7% | 9.2% | 26.2% | 27.3% | 13.4% | 15.6% | 13.0% | 11.8% | 19.7% | 17.9% | 14.4% | 12.8% | 15.1% | 16.7% | 8.2% | 9.0% | 11.4% | 13.3% | 23.4% | 25.3% | 25.8% | 24.2% | 20.5% | 19.7% | 20.5% | 21.6% | 25.2% | 23.4% | |
| -157.6% | -188.1% | -333.6% | -605.1% | -236.4% | -88.2% | -45.6% | -16.1% | 2.4% | 4.7% | -7.6% | 3.0% | 3.1% | 4.7% | 19.9% | 20.4% | 9.0% | 38.9% | 38.5% | 35.3% | 41.6% | 7.9% | 5.9% | 0.9% | 4.2% | 10.4% | 4.0% | 10.5% | 10.7% | 13.2% | 18.7% | 16.0% | 17.2% | 14.5% | 12.7% | 13.9% | 16.0% | 16.7% | 21.6% | 20.9% | |
| -118.3% | -147.1% | -265.1% | -526.0% | -208.8% | -62.7% | -27.0% | 0.5% | 17.0% | 17.0% | 0.1% | 7.3% | 12.1% | 17.4% | 32.5% | 34.1% | 21.8% | 20.3% | 24.9% | 23.8% | 30.1% | 20.6% | 8.5% | 10.2% | 12.7% | 21.7% | 14.8% | 16.8% | 21.6% | 19.2% | 31.0% | 23.3% | 19.6% | 23.7% | 20.4% | 21.1% | 22.1% | 26.2% | 26.8% | 25.8% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -35.8% | -44.8% | -81.0% | -63.7% | -55.9% | -38.3% | -29.1% | -13.8% | 2.2% | 4.4% | -9.6% | 3.7% | 3.7% | 5.8% | 25.2% | 24.6% | 11.6% | 36.2% | 33.3% | 28.5% | 33.0% | 6.5% | 5.1% | 0.9% | 3.8% | 9.0% | 3.8% | 9.5% | 9.5% | 11.2% | 15.5% | 13.5% | 14.2% | 13.2% | 12.1% | 12.9% | 14.2% | 14.7% | 19.6% | 19.1% | |
| -31.5% | -38.6% | -69.2% | -29.2% | -25.1% | -17.4% | -13.1% | -6.2% | 1.1% | 2.1% | -4.1% | 1.7% | 1.8% | 2.8% | 13.0% | 13.5% | 6.2% | 23.5% | 21.8% | 18.6% | 22.0% | 4.3% | 3.3% | 0.6% | 2.7% | 6.5% | 2.7% | 6.8% | 6.7% | 7.7% | 10.6% | 10.3% | 10.9% | 9.2% | 8.3% | 9.0% | 10.0% | 10.3% | 13.6% | 13.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -85 | -68 | -52 | 412 | 462 | 153 | 573 | 591 | 188 | 309 | 324 | 257 | 237 | 705 | 227 | 4.4 | -0.3 | 225 | 739 | 78 | 309 | 219 | 124 | 23 | -26 | -94 | 83 | 27 | -106 | -81 | -137 | -104 | -314 | – | – | – | -289 | – | – | – | |
| – | – | – | – | – | – | – | – | 4.3 | 5.5 | – | 4.6 | 3.6 | 8.2 | 1.0 | 0.0 | 0.0 | 1.5 | 5.5 | 0.7 | 1.6 | 1.6 | 1.0 | 0.5 | -0.2 | -0.4 | 0.7 | 0.1 | -0.4 | -0.2 | -0.2 | -0.2 | -0.5 | – | – | – | -0.4 | – | – | – | |
| 88.1% | 86.2% | 85.4% | 45.8% | 45.0% | 45.5% | 45.2% | 44.9% | 47.9% | 48.4% | 42.7% | 45.3% | 48.7% | 48.8% | 51.4% | 54.8% | 53.5% | 64.9% | 65.3% | 65.4% | 66.7% | 66.3% | 64.9% | 71.0% | 72.1% | 72.1% | 71.4% | 70.9% | 70.3% | 68.6% | 68.7% | 75.9% | 76.9% | 69.6% | 68.8% | 69.3% | 70.4% | 70.2% | 69.5% | 68.9% | |
| 0.0 | 0.0 | 0.0 | 2.1 | 2.1 | 1.1 | 2.1 | 2.0 | 0.9 | 0.9 | 1.0 | 0.8 | 0.7 | 1.3 | 0.6 | 0.5 | 0.5 | 0.4 | 0.9 | 0.3 | 0.5 | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | – | – | – | 0.0 | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.45 | -1.62 | -2.29 | -2.50 | -2.20 | -1.54 | -1.18 | -0.58 | 0.10 | 0.22 | -0.43 | 0.19 | 0.22 | 0.38 | 1.82 | 2.09 | 1.00 | 4.19 | 4.09 | 3.73 | 4.55 | 0.94 | 0.73 | 0.13 | 0.59 | 1.53 | 0.66 | 1.76 | 1.89 | 2.44 | 3.57 | 3.26 | 3.70 | 3.32 | 2.98 | 3.45 | 4.18 | 4.67 | 6.47 | 6.77 | |
| 0.92 | 0.86 | 0.69 | 0.41 | 0.93 | 1.74 | 2.60 | 3.59 | 4.28 | 4.71 | 5.69 | 6.38 | 7.03 | 8.11 | 9.14 | 10.24 | 11.17 | 10.76 | 10.65 | 10.56 | 10.95 | 11.94 | 12.37 | 13.56 | 14.03 | 14.77 | 16.46 | 16.70 | 17.64 | 18.45 | 19.13 | 20.40 | 21.50 | 22.89 | 23.54 | 24.85 | 26.17 | 27.91 | 30.00 | 32.38 | |
| 4.05 | 3.62 | 2.83 | 3.92 | 3.93 | 4.02 | 4.07 | 4.19 | 4.62 | 5.02 | 4.49 | 5.10 | 5.98 | 6.55 | 7.22 | 8.46 | 8.62 | 11.59 | 12.28 | 13.09 | 13.78 | 14.48 | 14.25 | 14.89 | 15.60 | 16.94 | 17.35 | 18.49 | 19.80 | 21.82 | 23.03 | 24.15 | 26.07 | 25.17 | 24.74 | 26.68 | 29.30 | 31.74 | 32.95 | 35.45 | |
| -1.09 | -1.27 | -1.82 | -2.17 | -1.94 | -1.09 | -0.70 | 0.02 | 0.73 | 0.80 | 0.00 | 0.47 | 0.85 | 1.41 | 2.97 | 3.49 | 2.44 | 2.18 | 2.65 | 2.51 | 3.30 | 2.46 | 1.05 | 1.39 | 1.79 | 3.20 | 2.44 | 2.80 | 3.81 | 3.53 | 5.93 | 4.76 | 4.22 | 5.41 | 4.80 | 5.23 | 5.79 | 7.30 | 8.04 | 8.35 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.